New research indicates that estrogen only therapy for younger postmenopausal women without a uterus may reduce their risk of developing breast cancer.
The new study was lead by Canadian researcher Dr. Joseph Ragaz, an oncologist at the University of British Columbia, who along with his colleagues took another look at data from the massive Women’s Health Initiative Study.
By analyzing all available data he and his team found that younger postmenopausal women without a uterus and who did not need to also take the hormone progestin were less likely to develop breast cancer while on estrogen therapy.
Women who go through menopause often turn to HRT to ease their symptoms and to look younger, and there have been a multitude of studies performed to determine its risk.
The study was presented at the San Antonio Breast Cancer Symposium.